NASDAQ:APHA Aphria (APHA) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free APHA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$15.38▼$15.3850-Day Range$13.14▼$18.3752-Week Range$2.78▼$32.29VolumeN/AAverage Volume21.83 million shsMarket Capitalization$4.87 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Aphria alerts: Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About Aphria Stock (NASDAQ:APHA)Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Read More Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. APHA Stock News HeadlinesSeptember 27, 2023 | benzinga.comSheep Ate 600lbs Of Cannabis While Sheltering From A Storm: Here's What They Did NextSeptember 25, 2023 | markets.businessinsider.comEwe Won't Believe It: Greek Sheep's 'Highly' Unconventional Cannabis Greenhouse AdventureApril 23, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… June 8, 2023 | markets.businessinsider.comTilray CFO Engages Shareholders On Reddit, Addresses Concerns And Company's Growth StrategyJanuary 3, 2023 | nypost.comHow to bet on Horse Racing: Complete guide to Horse Betting OnlineOctober 14, 2022 | fool.comWhy Owens & Minor Shares Plummeted 32.4% This Week - The Motley FoolOctober 11, 2022 | prnewswire.comThe Continued Legalization of Cannabis Creates Need for Intoxication Detection Devices - PR NewswireOctober 10, 2022 | finance.yahoo.comIndustrial hemp Market Size-2022 Will Revenue to Cross readjusted size of US$ 3259.5 million by 2028 Top Companies report covers, (It was also one of the primary plants to be rolled into usable fibre 50,000 years ago.) - Yahoo FinanceApril 23, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… October 8, 2022 | seekingalpha.comTilray Brands Stock: Pot Pops Then Drops - Seeking AlphaOctober 7, 2022 | law360.comJPay Founder Says Insider Trading Case Falls Short - Law360October 4, 2022 | businesswire.comGlobal Medical Marijuana Market Trends/Analysis Report 2022: A $65.8 Billion Industry by 2030 - Rapid Adoption of Cannabis in Therapeutic Applications - ResearchAndMarkets.com - Business WireOctober 1, 2022 | prnewswire.comGlobal Cannabis Extract Market to Reach $15.5 Billion by 2030 at a CAGR of 20.6% - PR NewswireSeptember 28, 2022 | businesswire.comGlobal Legal Cannabis Market Size, Trends & Analysis Report 2022-2030: Regulatory Scenario, Consumption Pattern, Potential Trade Opportunities, Case Studies, End-users, Competitive Landscape - ResearchAndMarkets.com - Business WireSeptember 27, 2022 | globenewswire.comCannabis Beverages Market to Reach USD 19,063.58 Million by - GlobeNewswireSeptember 26, 2022 | finance.yahoo.comGlobal Legal Cannabis Market Analysis Report 2022: A $134.4 Billion Industry by 2030, Growing at a CAGR of Over 25% - Yahoo FinanceSeptember 17, 2022 | seekingalpha.comTLRY Tilray Brands, Inc.September 14, 2022 | globenewswire.comWith 27.5% CAGR, Global CBD-Infused Beverages Market Size - GlobeNewswireSeptember 13, 2022 | prnewswire.comYourWay Cannabis Brands Provides Corporate Update - PR NewswireSeptember 13, 2022 | businesswire.comMorganti & Co., Announces that Class Certification Scheduled in the pending shareholder litigation against Auxly Cannabis Group, Inc. - Business WireSeptember 11, 2022 | benzinga.comJoana ScopelSeptember 10, 2022 | benzinga.comTilray Brands (NASDAQ:TLRY) – A Shareholder Lawsuit Stemming From Aphria Could Expose Tilray—Trouble In C - BenzingaSeptember 7, 2022 | investors.comIs TLRY Stock A Buy As Germany Gets Closer To Cannabis Legalization? - Investor's Business DailySeptember 2, 2022 | seekingalpha.comTLRY stock gains after debt agreement with JV partner (NASDAQ:TLRY) - Seeking AlphaSeptember 1, 2022 | law360.comCanadian Pot Co. Investors Win Class Cert. In Acquisition Suit - Law360August 31, 2022 | globenewswire.comIndustrial Hemp Market Worth USD 3259.5 million by 2028 | Growth, Size, Shares, Revenue, Types, Applications, Key Players, Top Countries, Growing Factors, Key Dynamics - GlobeNewswireAugust 25, 2022 | finance.yahoo.comTilray Medical Launches New Products and ‘CannaPoints’ Program to Support Patients Across Canada - Yahoo FinanceSee More Headlines Receive APHA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/11/2021Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolNASDAQ:APHA CUSIPN/A CIKN/A Webaphriainc.com Phone(844) 427-4742FaxN/AEmployees1,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-63,210,000.00 Net Margins-36.10% Pretax MarginN/A Return on Equity-2.30% Return on Assets-1.66% Debt Debt-to-Equity Ratio0.25 Current Ratio2.36 Quick Ratio1.17 Sales & Book Value Annual Sales$405.96 million Price / Sales12.00 Cash Flow$0.09 per share Price / Cash Flow166.43 Book Value$4.80 per share Price / Book3.20Miscellaneous Outstanding Shares316,795,000Free FloatN/AMarket Cap$4.87 billion OptionableOptionable Beta2.67 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Irwin D. Simon (Age 62)CEO & Chairman Comp: $5.23MMr. Carl A. MertonChief Financial OfficerDr. Christelle Gedeon L.L.B.Ph.D., Chief Legal Officer & Corp. Sec.Mr. James R. MeiersChief Operating Officer of Aphria LeamingtonMs. Denise Menikheim Faltischek (Age 48)Chief Strategy Officer & MD of Aphria Germany Comp: $449.68kMr. John B. SadlerVP of Investor RelationsMr. Bernard YeungSr. VP of Sales & MarketingMr. Victor Neufeld (Age 67)Special Advisor Mr. Cole Cacciavillani (Age 66)Special Advisor Mr. Randy DaigneauSr. VP of Supply ChainMore ExecutivesKey CompetitorsHalozyme TherapeuticsNASDAQ:HALOKrystal BiotechNASDAQ:KRYSCRISPR TherapeuticsNASDAQ:CRSPBausch + LombNYSE:BLCOGlaukosNYSE:GKOSView All Competitors APHA Stock Analysis - Frequently Asked Questions How were Aphria's earnings last quarter? Aphria Inc. (NASDAQ:APHA) announced its quarterly earnings data on Sunday, April, 11th. The company reported ($1.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $1.10. The firm had revenue of $153.60 million for the quarter, compared to analysts' expectations of $172.01 million. Aphria had a negative net margin of 36.10% and a negative trailing twelve-month return on equity of 2.30%. The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.02 EPS. Read the conference call transcript. What other stocks do shareholders of Aphria own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV), Alibaba Group (BABA), Mastercard (MA), Block (SQ), Abbott Laboratories (ABT), Alteryx (AYX), Big Lots (BIG) and BlackRock (BLK). This page (NASDAQ:APHA) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aphria Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
